Free Trial

Is Keurig-Dr. Pepper A Value Worth Buying? 

Is Keurig-Dr. Pepper A Value Worth Buying? 

Keurig-Dr. Pepper Is A Solid Play On Beverages 

Those looking for a value won’t find it in Keurig-Dr. Pepper (NYSE: KDP) but that doesn’t make it a bad purchase. The company is trading at roughly 22X its earnings compared to about 15X for the broad market which makes it quite an expensive stock for the 2.0% dividend yield that it pays. What these numbers don’t reveal is the health of the underlying beverage segment which is revealed in results from this company as well as from The Coca-Cola Company (NYSE: KO) and Pepsico (NASDAQ: PEP). The stock may look like a value compared to these peers with them trading at roughly 26.5X earnings but there is a reason for this as well. As attractive as the dividend is, both Pepsico and Coca-Cola are paying higher yields near 2.7%, and have a more stable history of dividend increases, which accounts for the difference. 

The takeaway is that Keurig-Dr. Pepper is a solid dividend payer and on track to raise the dividend within the next few quarters. The company is only paying out 47% of its TTM earnings and the balance sheet is sound. The company produced $599 million in FCF cash flow in the 2nd quarter of 2022 which puts the FCF payout ratio closer to 44% on an as-reported basis and leaves ample room for buybacks and dividend increases. As for buybacks, the company repurchased 2.5 million shares for $87.6 million during the quarter and still has $3.9 billion left under the current authorization which is worth about 7.5% of the current market cap. 

Keurig-Dr. Pepper Produces Real Growth 

Keurig-Dr. Pepper had a mixed quarter in terms of the analyst consensus but a good quarter in nearly every other way. The company served up $3.55 billion in revenue for a gain of 13.2% over last year beating the analyst consensus by 500 basis points. The strength was driven by both pricing and volume with pricing up 10.4% and volume up 3.1%. On a segment basis, the core Liquid Refreshment Beverages grew by 9.9% while the Coffee segment grew 3.8% and the Coffee Systems segment by 9%. 

The mixed part of the report is the margin which came under pressure due to one-off items, increased costs, and supply chain disruptions. The GAAP operating income fell by 22.1% because of the pressures, shaving 51% off the GAAP earnings, but the adjusted results are much better. The adjusted earnings, which only include the impacts of inflation, came in as expected at $0.39 and are up 2.6% versus last year on efforts to mitigate inflation. 

Turning to the guidance, the company is expecting to raise prices again in the second half and that should drive both top and bottom line results. The bad news is that inflationary pressures are also rising so, while revenue guidance was raised, the earnings guidance was maintained at the prior level. The takeaway, however, is that earnings and cash flow still support the dividend growth outlook. 

The Technical Outlook: Keurig-Dr. Pepper Reverses Within A Range

The price action in Keurig-Dr. Pepper is in a long-term uptrend but has been range bound for the last few quarters. The post-release action has the stock up slightly but above the mid-point of the range where it may trend higher. Assuming support is confirmed at the mid-point of the range, the stock could move up to the $39 level by the start of the 4th quarter and possibly move higher from there if the economic and earnings outlook is still positive. 

Is Keurig-Dr. Pepper A Value Worth Buying? 

→ I was wrong. Dead wrong. (From Porter & Company) (Ad)

Should you invest $1,000 in Keurig Dr Pepper right now?

Before you consider Keurig Dr Pepper, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.

While Keurig Dr Pepper currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Thomas Hughes
About The Author

Thomas Hughes

Contributing Author

Technical and Fundamental Analysis

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
PepsiCo (PEP)
4.6164 of 5 stars
$162.16-0.5%3.34%23.92Hold$183.92
Coca-Cola (KO)
4.7747 of 5 stars
$64.58+0.3%3.00%26.69Moderate Buy$72.36
Keurig Dr Pepper (KDP)
4.5873 of 5 stars
$32.65-0.6%2.82%19.79Moderate Buy$38.36
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs

MicroStrategy Stock: Riding Bitcoin’s Wave to New Highs

Bitcoin soared 60% since the election, reigniting interest in the crypto market. Crypto-related stocks like MicroStrategy are now seeing a big boost too.

Recent Videos

How Abacus Life is Transforming Life Insurance into Assets | MarketBeat CEO Series
NVIDIA Earnings: Can Blackwell Propel the Stock to $200+ in 2025?
These Top Stocks in 2024 Will Continue to be Big Winners in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines